Fiji vs Yemen: Access to anti-retroviral drugs, male
Fiji
28.0%
in 2024
Yemen
27.0%
in 2024
Fiji rank
133rd
Yemen rank
136th
Access to anti-retroviral drugs, male over time
- Fiji
- Yemen
How they compare
Fiji currently reports 28.0% against 27.0% in Yemen, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Yemen ahead.
Fiji ranks 133rd and Yemen ranks 136th of 141 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Yemen in 1.
Head to head by decade
| Decade | Fiji | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.2% | 0.8% | 40.4% | Fiji |
| 2010s | 33.5% | 12.7% | 20.8% | Fiji |
| 2020s | 19.6% | 24.0% | 4.4% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Fiji or Yemen?
- Fiji, at 28.0% against 27.0% in Yemen as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Fiji and Yemen?
- 1.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Yemen?
- 25 years are reported by both, from 2000 to 2024.
- How do Fiji and Yemen rank globally for access to anti-retroviral drugs, male?
- Fiji ranks 133rd and Yemen ranks 136th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.